Oragenics advances ONP-002 trial in Australia, signs device licensing deal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. ACN
3. IBM
4. MU
5. DPZ
6. PRIM
7. META
8. SPY
9. MTB
10. NAVN

Go back to Oragenics advances ONP-002 trial in Australia, signs device licensing deal
ORAGENICS (NYSE: OGEN) Delayed: 0.57 -0.01 (1.72%)
Previous Close $0.58    52 Week High $2.12 
Open $0.57    52 Week Low $0.33 
Day High $0.59    P/E N/A 
Day Low $0.57    EPS $-0.45 
Volume 12,924